Table of Contents
ToggleInhaled and ingested cannabis differ in how exposure occurs. Route, formulation and the amount of THC affect the experience and risks. Neither route is a universally better medical choice.

How inhalation and ingestion differ
Inhaled products deliver substances through the lungs, while swallowed products pass through the digestive system. Edible effects can be delayed and unpredictable. A promised onset or duration should not be treated as a personal dosing guide.
Arrange a medical cannabis evaluation
Smoking and vaporization expose the lungs to different product formulations. A cannabis product is not equivalent to an approved respiratory medicine.
Cannabis smoke and lung health
CDC information on cannabis and lung health explains that cannabis smoke can harm lung tissue and contains toxins and irritants. Smoking should not be promoted as a treatment for breathing problems.

Why an airway effect is not a treatment claim
A short-term physiological observation does not establish that inhaling cannabis treats an airway disease. Cannabis smoke can harm lung tissue.
Breath-holding and smoking techniques
A universal smoking technique cannot establish a safe exposure. Product composition and individual health factors matter.
Products used for inhalation
Flower and concentrates have different compositions. The product label and its actual formulation matter; the method alone does not establish safety.
Cannabis flower
Flower is dried plant material. Smoking flower produces combustion smoke.
Cannabis concentrates
Concentrates can contain substantially different cannabinoid amounts from flower. A product category does not establish a safe personal dose.
Cannabis inhalers
A device resembling an asthma inhaler should not be described as a substitute for prescribed asthma treatment or as delivering a universally correct cannabis dose.
Cannabis ingestion
Edibles and drinks are swallowed products. The NIH cannabis evidence and safety overview discusses adverse effects and accidental ingestion risks.
Arrange a medical cannabis evaluation

Oral cannabis product formats
Labels may describe baked goods, sweets, beverages or oils. Their cannabinoid amounts and formulation can differ substantially.
Cannabis baked goods
Food ingredients and cannabinoid content vary by product. Appearance does not establish THC content.
Gummies and chocolates
Products that resemble ordinary sweets can be consumed unintentionally. Packaging and identification matter.
Cannabis beverages
Formulations differ. Claims of a guaranteed five-minute onset or a predictable intensity should not be used as individual advice.
Products used in the mouth
Products labeled for use under the tongue or in the mouth should not be assumed to have the same absorption as a swallowed edible.
Cannabis tinctures
Tinctures differ in ingredients and cannabinoid concentration. Their category does not establish clinical benefit.
Cannabis sprays
Sprays differ in formulation and intended use. Follow the actual product information rather than a universal dose or timing claim.
CBD evidence and risks
Consumer CBD products should not be described as proven treatments for a broad list of illnesses. Prescription cannabinoid approvals do not extend to every CBD oil, edible or vape.
Medical cannabis evaluations
A medical evaluation considers the individual and applicable state requirements. A certification is not a guarantee that a particular product will be effective or risk free.

